Women in Science - Nuclear Medicine 2024

1,277
Total downloads
5,583
Total views and downloads

Articles

OPINION

Published on 09 Feb 2024

Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)

Marigdalia K. Ramirez-Fort
Casey K. Gilman
Jacob S. Alexander
Barbara Meier-Schiesser
Arjan Gower
Mojtaba Olyaie
Neel Vaidya
Kiarash Vahidi
Yuxin Li
2 more
Corinne Deurdulian

Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)

doi 10.3389/fmed.2023.1304718

957 views

ORIGINAL RESEARCH

Published on 17 Jan 2024

Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarker

Caroline Burgard
Jakob Engler
Arne Blickle
Mark Bartholomä
Stephan Maus
Andrea Schaefer-Schuler
Fadi Khreish
Samer Ezziddin
Florian Rosar

Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarker

doi 10.3389/fmed.2023.1339160

1,422 views
1 citation

ORIGINAL RESEARCH

Published on 25 Jul 2023

ATN profile classification across two independent prospective cohorts

Débora E. Peretti
Federica Ribaldi
Max Scheffler
Linjing Mu
Valerie Treyer
Anton F. Gietl
Christoph Hock
Giovanni B. Frisoni
Valentina Garibotto

doi 10.3389/fmed.2023.1168470

1,764 views
1 citation

Share on

Frontiers in Medicine

Frontiers in Medicine

Nuclear Medicine

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

5,583Topic views
3,614Article views
1,277Article downloads